News summary
[Health Yuan: Obtained the drug registration certificate of fluticasone propionate suspension for aerosol inhalation] Securities Times e Company Newsyojucasinonodepositbonuscodes2022, Health Yuan (600380) announced on the evening of May 27 that its holding subsidiary Shanghai Fangyu received the approval of the State Food and Drug Administration for suspension for nebulized inhalation of fluticasone propionateyojucasinonodepositbonuscodes2022...
Newsletter text
[Health Yuan: Obtained the drug registration certificate of fluticasone propionate aerosol suspension for inhalation] Securities Times e Company News, Health Yuan (600380) announced on the evening of May 27 that its holding subsidiary Shanghai Fangyu received the "Drug Registration Certificate" of fluticasone propionate aerosol suspension for inhalation approved and issued by the Administration. This product is suitable for the treatment of mild to moderate acute asthma attacks in children and adolescents aged 4 - 16.